Understanding the advantages and disadvantages of different molecules is essential in planning evaluation and treatment of patients. With a focus towards R&D, our team and expert advisors keep abreast of the newest research published in the field of nuclear medicine.
FDI Care aims to provide patients and medical professionals radiopharmaceuticals for both diagnostic & therapeutic applications. Below are the molecules available from our state-of-the-art facility:
- (F-18) FDG – Fluorodeoxyglucose: Indicates regions of glucose metabolism for diagnosis
- (F-18) NaF – Sodium Flouride: Identifies specific areas of bone metastases
- (F-18) PSMA: Provides superior detection & high-contrast images for diagnosis of prostate cancer
- (F-18) DOPA: Early detection & monitoring progression of Parkinson’s disease, and evaluation of neuroendocrine tumors